12 Sep 9 October – LaBiotech.eu Refresh #10 in Basel
LaBiotech is back to Basel, one of the most vibrant biotech hubs in Europe, to present another edition of Refresh, a meetup-style event which aims to gather the local biotech leaders, innovators, entrepreneurs and investors in a free and “down-to-earth” setting. This time around, two well-known players of the local biotech ecosystem are invited to share their stories and lessons learned along the way: Ulf Grawunder, CEO and co-founder of NBE Therapeutics, a biotech startup focused on developing next-generation ADCs for cancer treatment and Chandra Leo, a highly experienced healthcare venture capitalist and partner at HBM.
When: October 9th 2018, 18:30 to 20:30
Where: Halle 7, Gundeldingerfeld, Dornacherstrasse 192, Basel.
|19:00||1st Fireside Chat – Ulf Grawunder (CEO, NBE Thx)|
|19:30||2nd Fireside Chat – Chandra Leo (Partner, HBM)|
Participation to the event is free of charge; however, your registration is mandatory.
Ulf has been an entrepreneur working on antibodies since he started his first company, 4-Antibody, in 2004. He moved on when it was acquired by Aegnus in 2014 and started NBE Therapeutics in Basel to move into ADCs and iron out the kinks. He has been rocking it here and has invented two new patent-pending techs to develop innovative antibody-based drugs, including next-generation ADCs for cancer therapies.
If you are interested in Venture Capital then Chandra is a great person to talk to. He has over 15 years of experience and is currently a partner at HBM Partners, one of the world’s large investment groups focused on healthcare and life sciences. Chandra is also on the board of a lot of different companies such as Symbiomix Therapeutics, Delenex Therapeutics, & ChenoCentryx for the HBM investments. He is an investment guru.